These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8608722)

  • 21. The molecular basis of poliovirus neurovirulence.
    Ohka S; Nomoto A
    Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
    Racaniello VR
    Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.
    Pfeiffer JK
    Adv Virus Res; 2010; 77():85-118. PubMed ID: 20951871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event.
    Mueller S; Wimmer E; Cello J
    Virus Res; 2005 Aug; 111(2):175-93. PubMed ID: 15885840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic mice and the pathogenesis of poliomyelitis.
    Racaniello VR; Ren R
    Arch Virol Suppl; 1994; 9():79-86. PubMed ID: 8032284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent insights into poliovirus pathogenesis.
    Ohka S; Nomoto A
    Trends Microbiol; 2001 Oct; 9(10):501-6. PubMed ID: 11597452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus neurovirulence and attenuation, a conceptual framework.
    John TJ
    Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The assessment of OPV vaccines by the monkey neurovirulence test: why and how to qualify the experts in histology of central nervous system.
    Poirier B; Morgeaux S; Fuchs F
    Vaccine; 2002 Nov; 21(1-2):115-9. PubMed ID: 12443669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of the correlation of the RCT-40 marker of poliomyelitis type 3 virus with neurovirulence for monkeys].
    Krutianskaia GL; El'bert LB; Ral'f NM; Tiufanov AV
    Vopr Virusol; 1967; 12(6):680-2. PubMed ID: 4304896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Poliovirus susceptibility in cultured cells--an answer to Enders].
    Koike S
    Uirusu; 2006 Jun; 56(1):59-66. PubMed ID: 17038813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The CNS lesion in monkeys spinally infected with the vaccinal poliomyelitis virus].
    Tereshkina NV; Lavrova IK; Kozlov VG; Sobolev SG; Tiufanov AV; Koroleva GA; Grigor'eva LV; Chigirinskiĭ AE
    Vopr Virusol; 1991; 36(3):222-6. PubMed ID: 1654009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What threat from persistent vaccine-related poliovirus?
    MacLennan C; MacLennan J
    Lancet; 2005 Jul 30-Aug 5; 366(9483):351-3. PubMed ID: 16054925
    [No Abstract]   [Full Text] [Related]  

  • 35. The attenuation of poliovirus neurovirulence.
    Almond JW
    Annu Rev Microbiol; 1987; 41():153-80. PubMed ID: 2825586
    [No Abstract]   [Full Text] [Related]  

  • 36. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis.
    Brown DM; Kauder SE; Cornell CT; Jang GM; Racaniello VR; Semler BL
    J Virol; 2004 Feb; 78(3):1344-51. PubMed ID: 14722289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virology. Active poliovirus baked from scratch.
    Couzin J
    Science; 2002 Jul; 297(5579):174-5. PubMed ID: 12114601
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells.
    Guo R; Chen SF; Luo GX; Luo QS; Xu QF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.